Marianna Ruzinova

12PUBLICATIONS
138CO-AUTHORS
Gene and molecular therapyMolecular targetsInnate immunityPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 24, 2026
Mosaic TLR8 gain-of-function in an elderly female treated with JAK inhibitor and adjunctive therapy.

|Sep 04, 2026
Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

|Apr 24, 2026
Development of Colonic Polyposis in a Woman With Chronic Myeloid Leukemia Treated With Dasatinib.

|Apr 20, 2026
Prolonged KRAS-MAPK Inhibition Induces Interferon Signaling That Promotes Cell State Transition and Confers Therapeutic Vulnerabilities.

|Nov 07, 2025
Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity.

Sheela R Damle, Jason A Carter, Kristin E Goodsell

|Dec 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.

Naomi Yamamoto, Stephanie Dobersch, Ian Loveless

Pageof 2

Frequent Collaborators

3 joint publications

Kian-Huat Lim

3 joint publications

Kiran Vij

2 joint publications

Malachi Griffith

2 joint publications

Thomas Walsh